Back
Tango Therapeutics, Inc. Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Sell
41
TNGX
Tango Therapeutics, Inc.
Last Price:
$8.69
Seasonality Move:
-27.62%
Buy
61
LYEL
Lyell Immunopharma, Inc.
Last Price:
$38.65
Seasonality Move:
-16.78%
Sell
41
Tango Therapeutics, Inc. (TNGX)
is a Sell
Is Tango Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Tango Therapeutics, Inc. [TNGX] share price is $8.53. The Score for TNGX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TNGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.33. The Score for LYEL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TNGX Stock Price Chart
What is Tango Therapeutics, Inc.'s stock price today?
-
The Tango Therapeutics, Inc. share price today is $8.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNGX is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.33Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
TNGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.11 | Buy |
| Relative Strength Index (14 RSI): | 42.54 | Sell |
| Chaikin Money Flow: | -882517 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.59 - 10.19) | Sell |
| Bollinger Bands (100): | (6.85 - 9.09) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.24 | Buy |
| Relative Strength Index (14 RSI): | 78.97 | Buy |
| Chaikin Money Flow: | -246560 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.8 - 33.24) | Buy |
| Bollinger Bands (100): | (10.76 - 24.28) | Buy |
TNGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.79 | Sell |
| 20-day SMA: | 9.46 | Sell |
| 50-day SMA: | 8.79 | Sell |
| 200-day SMA: | 5.6 | Buy |
| 8-day EMA: | 6.13 | Buy |
| 20-day EMA: | 3.38 | Buy |
| 50-day EMA: | 1.56 | Buy |
| 200-day EMA: | 0.42 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34 | Buy |
| 20-day SMA: | 29.06 | Buy |
| 50-day SMA: | 22.08 | Buy |
| 200-day SMA: | 13.64 | Buy |
| 8-day EMA: | 33.98 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 23.99 | Buy |
| 200-day EMA: | 17.62 | Buy |
Tango Therapeutics, Inc. Earnings Growth & TNGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.40 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
Tango Therapeutics, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||